Cargando…
Mixed Neuroendocrine and Non-Neuroendocrine Neoplasm of Pancreas: What Do We Know, What Have We Learnt?
Pancreatic adeno-mixed neuroendocrine non-endocrine (pMINEN) tumors are extremely rare [Pancreatology. 2021;21(1):224–235]. They are known to have distal metastasis at presentation and have a comparatively lower survival rate than similar staged neuroendocrine (NEN) carcinoma, adenocarcinoma, and sm...
Autores principales: | Dhakre, Vijay W., Galande, Sneha Tukaram, Patil, Varsha Gunvant, Shah, Nikita C., Rathod, Chetan, Sethna, Kaiumarz S., Amrapurkar, Anjali D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123363/ https://www.ncbi.nlm.nih.gov/pubmed/37102120 http://dx.doi.org/10.1159/000528759 |
Ejemplares similares
-
Successful Use of Direct Splenic Vein Anastomosis to the Interposition Internal Jugular Vein Graft after Extended Pancreatoduodenectomy to Avoid Sinistral Portal Hypertension
por: Dhakre, Vijay W., et al.
Publicado: (2022) -
Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023) -
Primary Hepatic Neuroendocrine Tumor: What Do We Know Now?
por: Quartey, Benjamin
Publicado: (2011) -
The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013) -
Defining transposition: What have we learnt?
por: Roderick, Max E., et al.
Publicado: (2021)